141 related articles for article (PubMed ID: 34767949)
1. MmpL3, the trehalose monomycolate transporter, is stable in solution in several detergents and can be reconstituted into peptidiscs.
Ung KL; Alsarraf H; Kremer L; Blaise M
Protein Expr Purif; 2022 Mar; 191():106014. PubMed ID: 34767949
[TBL] [Abstract][Full Text] [Related]
2. Cryo-EM structure of the trehalose monomycolate transporter, MmpL3, reconstituted into peptidiscs.
Couston J; Guo Z; Wang K; Gourdon P; Blaise M
Curr Res Struct Biol; 2023; 6():100109. PubMed ID: 38034087
[TBL] [Abstract][Full Text] [Related]
3. Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria.
Fay A; Czudnochowski N; Rock JM; Johnson JR; Krogan NJ; Rosenberg O; Glickman MS
mBio; 2019 Jun; 10(3):. PubMed ID: 31239378
[TBL] [Abstract][Full Text] [Related]
4. The crystal structure of the mycobacterial trehalose monomycolate transport factor A, TtfA, reveals an atypical fold.
Ung KL; Alsarraf HMAB; Kremer L; Blaise M
Proteins; 2020 Jun; 88(6):809-815. PubMed ID: 31833106
[TBL] [Abstract][Full Text] [Related]
5. Insights into substrate transport and water permeation in the mycobacterial transporter MmpL3.
Li Y; Acharya A; Yang L; Liu J; Tajkhorshid E; Zgurskaya HI; Jackson M; Gumbart JC
Biophys J; 2023 Jun; 122(11):2342-2352. PubMed ID: 36926696
[TBL] [Abstract][Full Text] [Related]
6. Structures of the mycobacterial membrane protein MmpL3 reveal its mechanism of lipid transport.
Su CC; Klenotic PA; Cui M; Lyu M; Morgan CE; Yu EW
PLoS Biol; 2021 Aug; 19(8):e3001370. PubMed ID: 34383749
[TBL] [Abstract][Full Text] [Related]
7. Targeting MmpL3 for anti-tuberculosis drug development.
Bolla JR
Biochem Soc Trans; 2020 Aug; 48(4):1463-1472. PubMed ID: 32662825
[TBL] [Abstract][Full Text] [Related]
8. MmpL3 is a lipid transporter that binds trehalose monomycolate and phosphatidylethanolamine.
Su CC; Klenotic PA; Bolla JR; Purdy GE; Robinson CV; Yu EW
Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11241-11246. PubMed ID: 31113875
[TBL] [Abstract][Full Text] [Related]
9. 1
Korycka-Machała M; Viljoen A; Pawełczyk J; Borówka P; Dziadek B; Gobis K; Brzostek A; Kawka M; Blaise M; Strapagiel D; Kremer L; Dziadek J
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332069
[TBL] [Abstract][Full Text] [Related]
10. Inhibition Mechanism of Anti-TB Drug SQ109: Allosteric Inhibition of TMM Translocation of Mycobacterium Tuberculosis MmpL3 Transporter.
Carbone J; Paradis NJ; Bennet L; Alesiani MC; Hausman KR; Wu C
J Chem Inf Model; 2023 Aug; 63(16):5356-5374. PubMed ID: 37589273
[TBL] [Abstract][Full Text] [Related]
11. Acetylation of trehalose mycolates is required for efficient MmpL-mediated membrane transport in Corynebacterineae.
Yamaryo-Botte Y; Rainczuk AK; Lea-Smith DJ; Brammananth R; van der Peet PL; Meikle P; Ralton JE; Rupasinghe TW; Williams SJ; Coppel RL; Crellin PK; McConville MJ
ACS Chem Biol; 2015 Mar; 10(3):734-46. PubMed ID: 25427102
[TBL] [Abstract][Full Text] [Related]
12. Structure-Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis.
Belardinelli JM; Yazidi A; Yang L; Fabre L; Li W; Jacques B; Angala SK; Rouiller I; Zgurskaya HI; Sygusch J; Jackson M
ACS Infect Dis; 2016 Oct; 2(10):702-713. PubMed ID: 27737557
[TBL] [Abstract][Full Text] [Related]
13. Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis.
Li W; Upadhyay A; Fontes FL; North EJ; Wang Y; Crans DC; Grzegorzewicz AE; Jones V; Franzblau SG; Lee RE; Crick DC; Jackson M
Antimicrob Agents Chemother; 2014 Nov; 58(11):6413-23. PubMed ID: 25136022
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the oligomeric state of mycobacterial membrane protein large 3 and its interaction with SQ109 with native cell membrane nanoparticles system.
Qiu W; Guo Y
Biochim Biophys Acta Biomembr; 2022 Feb; 1864(1):183793. PubMed ID: 34655545
[TBL] [Abstract][Full Text] [Related]
15. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
[TBL] [Abstract][Full Text] [Related]
16. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.
Tahlan K; Wilson R; Kastrinsky DB; Arora K; Nair V; Fischer E; Barnes SW; Walker JR; Alland D; Barry CE; Boshoff HI
Antimicrob Agents Chemother; 2012 Apr; 56(4):1797-809. PubMed ID: 22252828
[TBL] [Abstract][Full Text] [Related]
17. A piperidinol-containing molecule is active against
Dupont C; Chen Y; Xu Z; Roquet-Banères F; Blaise M; Witt AK; Dubar F; Biot C; Guérardel Y; Maurer FP; Chng SS; Kremer L
J Biol Chem; 2019 Nov; 294(46):17512-17523. PubMed ID: 31562241
[No Abstract] [Full Text] [Related]
18. Corrigendum to "MmpL3, the trehalose monomycolate transporter, is stable in solution in several detergents and can be reconstituted into peptidiscs" [Protein Expr. Purif. 191 (March 2022) 106014].
Ung KL; Alsarraf H; Kremer L; Blaise M
Protein Expr Purif; 2022 Aug; 195-196():106088. PubMed ID: 35365368
[No Abstract] [Full Text] [Related]
19. Mutations in MmpL3 alter membrane potential, hydrophobicity and antibiotic susceptibility in Mycobacterium smegmatis.
McNeil MB; Dennison D; Parish T
Microbiology (Reading); 2017 Jul; 163(7):1065-1070. PubMed ID: 28703701
[TBL] [Abstract][Full Text] [Related]
20. Multiple Mutations in Mycobacterium tuberculosis MmpL3 Increase Resistance to MmpL3 Inhibitors.
McNeil MB; O'Malley T; Dennison D; Shelton CD; Sunde B; Parish T
mSphere; 2020 Oct; 5(5):. PubMed ID: 33055263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
